Analysis of human carbonic anhydrase II: Docking reliability and receptor-based 3D-QSAR study

Journal of Chemical Information and Modeling

Volumn 47, Issue 2, 2007, Pages 515-525

  Tuccinardi, Tiziano ^a   Nuti, Elisa ^a   Ortore, Gibriella ^a   Supuran, Claudiu T ^b   Rossello, Armando ^a   Martinelli, Adriano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; DISEASES; LIGANDS; MATHEMATICAL MODELS; MOLECULAR STRUCTURE; PATHOLOGY;

CARBONIC ANHYDRASE (CA); HUMAN CARBONIC ANHYDRASE; LIGAND PROPERTIES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP (QSAR);

ENZYME INHIBITION;

CARBONATE DEHYDRATASE II; ENZYME INHIBITOR; LIGAND;

ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER PROGRAM; DRUG ANTAGONISM; HUMAN; METABOLISM; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; X RAY CRYSTALLOGRAPHY;

CARBONIC ANHYDRASE II; COMPUTATIONAL BIOLOGY; CRYSTALLOGRAPHY, X-RAY; ENZYME INHIBITORS; HUMANS; IMAGING, THREE-DIMENSIONAL; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REPRODUCIBILITY OF RESULTS; SOFTWARE;

EID: 34247260949     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci600469w     Document Type: Article

References (36)

1. Smith H. J.; Simons C. Enzymes and their Inhibition: Drug Development; CRC Press: Boca Raton, FL, 2005; pp l - 308.
2. Chegwidden, W. R.; Dodgson, S. J.; Spencer, I. M. The Roles of Carbonic Anhydrase in Metabolism, Cell Growth and Cancer in Animals. In The Carbonic Anhydrases: New Horizons; Chegwidden, W. R., Carter, N. D., Edwards, Y. H., Eds.; Birkhauser Verlag: Basel, Switzerland, 2000; pp 343-363.
3. Schuman, J. S. Short- and Long-Term Safety of Glaucoma Drugs. Expert Opin. Drug Saf. 2002, 1, 181-194.
4. Supuran, C. T.; Scozzafava, A. Applications of Carbonic Anhydrase Inhibitors and Activators in Therapy. Expert Opin. Ther. Pal. 2002, 12, 217-242.
5. Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic Anhydrase Inhibitors. Med. Res. Rev. 2003, 23, 146-189.
6. Alterio, V.; Vitale, R. M.; Monti, S. M.; Pedone, C.; Scozzafava, A.; Cecchi, A.; De Simone, G.; Supuran, C. T. Carbonic Anhydrase Inhibitors: X-ray and Molecular Modeling Study for the Interaction of a Fluorescent Antitumor Sulfonamide with Isozyme II and IX. J. Am. Chem. Soc. 2006, 128, 8329-8335.
7. Fisher, Z.; Hernandez Prada, J. A.; Tu, C.; Duda, D.; Yoshioka, C.; An, H.; Govindasamy, L.; Silverman, D. N.; McKenna, R. Structural and Kinetic Characterization of Active-Site Histidine as a Proton Shuttle in Catalysis by Human Carbonic Anhydrase II. Biochemistry 2005, 44, 1097-1105.
8. Winum, J. Y.; Scozzafava, A.; Montero, J. L.; Supuran, C. T. New Zinc Binding Motifs in the Design of Selective Carbonic Anhydrase Inhibitors. Mini Rev. Med. Chem. 2006, 6, 921-936.
9. Clare, B.W.; Supuran, C. T. QSAR Studies of Sulfonamide Carbonic Anhydrase Inhibitors. In Carbonic Anhydrase, Its Inhibitors and Activators; Supuran, C. T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; pp 149-182.
10. Melagraki, G.; Afantitis. A.; Sarimveis, H.; Igglessi-Markopoulou, O.; Supuran, C. T. QSAR Study on Para-Substituted Aromatic Sulrbnamides as Carbonic Anhydrase II Inhibitors Using Topological Information Indices. Bioorg. Med. Chem. 2006, 14, 1108-1114.
11. Gruneberg, S.: Wendt, B.; Klebe, G. Subnanomolar Inhibitors from Computer Screening: A Model Study Using Human Carbonic Anhydrase II. Angew. Chem., Int. Ed. 2001, 40, 389-393.
12. Gruneberg, S.; Stubbs, M. T.; Klebe, G. Successful Virtual Screening for Novel Inhibitors of Human Carbonic Anhydrase: Strategy and Experimental Confirmation. J. Med. Chem. 2002, 45, 3588-3602.
13. Hillebrecht, A.; Supuran, C. T.; Klebe, G. Integrated Approach Using Protein and Ligand Information to Analyze Selectivity- and Affinity-Determining Features of Carbonic Anhydrase Isozymes. Chem. Med. Chem. 2006, 1, 839-853.
14. Weber, A.; Bohm, M.; Supuran, C. T.; Scozzafava, A.; Sotriffer. C. A.; Klebe, G. 3D QSAR Selectivity Analyses of Carbonic Anhydrase Inhibitors: Insights for the Design of Isozyme Selective Inhibitors. J. Chem. Inf. Model. 2006, 46, 2737-2760.
15. Jones, G.; Willett, P.; Glen, R. C; Leach, A. R.; Taylor, R. Development and Validation of a Genetic Algorithm for Flexible Docking. J. Mol. Biol. 1997, 267, 727-748.
16. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235-242.
17. Maestro, version 7.5; Schrödinger Inc.: Portland, OR, 2005.
18. Macromodel, version 8.5; Schrödinger Inc.: Portland, OR, 1999.
19. Ragno, R.; Frasca, S.; Manetti, F.; Brizzi, A.; Massa, S. HIV-Reverse Transcriptase Inhibition: Inclusion of Ligand-Induced Fit by Cross-Docking Studies. J. Med. Chem. 2005, 48, 2002-2012.
20. Bursulaya, B. D.; Totrov, M.; Abagyan, R.; Brooks, C. L., III. Comparative Study of Several Algorithms for Flexible Ligand Docking. J. Comput.-Aided Mol. Des. 2003, 17, 755-763.
21. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. Automated Docking Using a Lamarckian Genetic Algorithm and Empirical Binding Free Energy Function. J. Comput. Chem. 1998, 19, 1639-1662.
22. Hu, X.; Shelver, W. H. Docking Studies of Matrix Metalloproteinase Inhibitors: Zinc Parameter Optimization to Improve the Binding Free Energy Prediction. J. Mol. Graphics Modell. 2003, 22, 115-126.
23. Hu, X.; Balaz, S.; Shelver, W. H. A Practical Approach to Docking of Zinc Metalloproteinase Inhibitors. J. Mol. Graphics Modell. 2004, 22, 293-307.
24. GOLPE 4.5; Multivariate Infometric Analysis Srl.: Perugia, Italy, 1999.
25. GRID, version 22a; Molecular Discovery Ltd.: Oxford, U. K., 2004.
26. Ilies, M.; Supuran, C. T.; Scozzafava, A.; Casini, A.; Mincione, F.; Menabuoni, L.; Caproiu, M. T.; Maganu, M.; Banciu, M. D. Carbonic Anhydrase Inhibitors: Sulfonamides Incorporating Furan-, Thiopheneand Pyrrole-Carboxamido Groups Possess Strong Topical Intraocular Pressure Lowering Properties as Aqueous Suspensions. Bioorg. Med. Chem. 2000, 8, 2145-2155.
27. Scozzafava, A.; Menabuoni, L.; Mincione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Carbonic Anhydrase Inhibitors. Synthesis of Water-Soluble, Topically Effective, Intraocular Pressure-Lowering Aromatic/Heterocyclic Sulfonamides Containing Cationic or Anionic Moieties: Is the Tail More Important Than the Ring? J. Med. Chem. 1999, 42, 2641-2650.
28. Pastor, M.; Cruciani, G.; Clementi, S. Smart Region Definition: A New Way to Improve the Predictive Ability and Interpretability of Three-Dimensional Quantitative Structure-Activity Relationships. J. Med. Chem. 1997, 40, 1455-1464.
29. Vullo, D.; Franchi, M.; Gallon, E.; Antel, J.; Scozzafava, A.; Supuran, C. T. Carbonic Anhydrase Inhibitors. Inhibition of Mitochondrial Isozyme V with Aromatic and Heterocyclic Sulfonamides. J. Med. Chem. 2004, 47, 1272-1279.
30. Hies, M. A.; Vullo, D.; Pastorek, J.; Scozzafava, A.; Ilies, M.; Caproiu, M. T.; Pastorekova, S.; Supuran, C. T. Carbonic Anhydrase Inhibitors. Inhibition of Tumor-Associated Isozyme IX by Halogenosulfanilamide and Halogenophenylaminobenzolamide Derivatives. J. Med. Chem. 2003, 46, 2187-2196.
31. Borras, J.; Scozzafava, A.; Menabuoni, L.; Mincione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Carbonic Anhydrase Inhibitors: Synthesis of Water-Soluble, Topically Effective Intraocular Pressure Lowering Aromatic/Heterocyclic Sulfonamides Containing 8-Quinoline-sulfonyl Moieties: Is the Tail More Important Than the Ring? Bioorg. Med. Chem. 1999, 7, 2397-2406.
32. Winum, J. Y.; Dogne, J. M.; Casini, A.; de Levai, X.; Montera, J. L.; Scozzafava, A.; Vullo, D.; Innocenti, A.; Supuran, C. T. Carbonic Anhydrase Inhibitors: Synthesis and Inhibition of Cytosolic/Membrane-Associated Carbonic Anhydrase Isozymes I, II, and IX with Sulfonamides Incorporating Hydrazino Moieties. J. Med. Chem. 2005, 48, 2121-2125.
33. Garaj, V.; Puccetti, L.; Fasolis, G.; Winum, J. Y.; Montera, J. L.; Scozzafava, A.; Vullo, D.; Innocenti, A.; Supuran, C. T. Carbonic Anhydrase Inhibitors: Novel Sulfonamides Incorporating 1,3,5-Triazine Moieties as Inhibitors of the Cytosolic and Tumour-Associated Carbonic Anhydrase Isozymes I, II and IX. Bioorg. Med. Chem. Lett. 2005, 75, 3102-3108.
34. Chazalette, C.; Masereel, B.; Rolin, S.; Thiry, A.; Scozzafava, A.; Innocenti, A.; Supuran, C. T. Carbonic Anhydrase Inhibitors. Design of Anticonvulsant Sulfonamides Incorporating Indane Moieties. Bioorg. Med. Chem. Lett. 2004, 14, 5781-5786.
35. Casini, A.; Winum, J. Y.; Montero, J. L.; Scozzafava, A.; Supuran, C. T. Carbonic Anhydrase Inhibitors: Inhibition of Cytosolic Isozymes I and II with Sulfamide Derivatives. Bioorg. Med. Chem. Lett. 2003, 13, 837-840.
36. Mincione, F.; Starnotti, M.; Menabuoni, L.; Scozzafava, A.; Casini, A.; Supuran, C. T. Carbonic Anhydrase Inhibitors: 4-Sulfamoylbenzenecarboxamides and 4-Chloro-3-sulfamoyl-benzenecarboxamides with Strong Topical Antiglaucoma Properties. Bioorg. Med. Chem. Lett. 2001, 11, 1787-1791.